Potential for Gut Peptide-Based Therapy in Postprandial Hypotension

Area of Science:

• Cardiovascular Physiology
• Gastroenterology
• Endocrinology

Background:

• Postprandial hypotension (PPH) is an under-recognized disorder caused by insufficient cardiovascular compensation to blood pooling in the splanchnic circulation after meals.
• Current PPH management strategies are often ineffective.
• Meal characteristics, gastric emptying, and nutrient absorption significantly influence postprandial cardiovascular adjustments.

Purpose of the Study:

• To review the role of gut peptides in the cardiovascular response to meals.
• To explore the potential of these gut peptides in managing PPH.

Main Methods:

• Literature review focusing on nutrient-gut interactions and neurohormonal responses.
• Analysis of the effects of glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic peptide (GIP), and somatostatin on postprandial hemodynamics.

Main Results:

• The small intestine is a key site for nutrient-gut interactions and the release of regulatory peptides.
• Gut peptides such as GLP-1, GIP, and somatostatin have significant effects on the cardiovascular system post-meal.
• These peptides modulate the haemodynamic profile in response to nutrient ingestion.

Conclusions:

• Gut peptides play a crucial role in mediating the cardiovascular adjustments following a meal.
• Targeting these gut peptides presents a promising avenue for developing improved therapies for postprandial hypotension.